According to Seres Therapeutics's latest financial reports the company's current revenue (TTM ) is โฌ1 Million. In 2025 the company made a revenue of โฌ0.67 Million an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.